Stockport, United Kingdom

Alexander Anthony Oldham


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alexander Anthony Oldham: Innovator in Neurological Treatments

Introduction

Alexander Anthony Oldham is a notable inventor based in Stockport, GB. He has made significant contributions to the field of medicine, particularly in the treatment of neurological disorders. His work focuses on innovative solutions that address critical health issues.

Latest Patents

Oldham holds a patent for "Angiotensin II antagonists against disorders associated with impaired neuronal conduction velocity, especially diabetic neuropathy." This invention relates to the use of angiotensin II antagonists in treating or preventing the development of disease conditions associated with impaired neuronal conduction velocity, such as diabetic neuropathy. The patent also covers pharmaceutical compositions that include an angiotensin II antagonist along with other agents beneficial for treating these conditions.

Career Highlights

Oldham is associated with Zeneca Limited, where he has contributed to various research initiatives. His work has been instrumental in advancing treatments for conditions that affect neuronal conduction, showcasing his commitment to improving patient outcomes.

Collaborations

Throughout his career, Oldham has collaborated with notable colleagues, including Frank Carey and Norman Cameron. These partnerships have fostered a collaborative environment that enhances innovation and research in the pharmaceutical field.

Conclusion

Alexander Anthony Oldham's contributions to medical science, particularly in the realm of neurological treatments, highlight his role as an influential inventor. His patent on angiotensin II antagonists represents a significant advancement in addressing disorders related to neuronal conduction.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…